sFlt1-i13 V5
(Plasmid
#86044)
-
Purposehuman Soluble Flt1 isoform i13 (terminates in intron 13)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 86044 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneTOPO Directional
-
Backbone manufacturerthermofisher
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namehuman soluble Flt1 isoform i13
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2204
-
Mutationisoform i13 (terminates in intron 13)
-
Entrez GeneFLT1 (a.k.a. FLT, FLT-1, VEGFR-1, VEGFR1)
- Promoter CMV
-
Tags
/ Fusion Proteins
- 6xHis (C terminal on backbone)
- V5 (C terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-Rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
sFlt1-i13 V5 was a gift from Christie Thomas (Addgene plasmid # 86044 ; http://n2t.net/addgene:86044 ; RRID:Addgene_86044) -
For your References section:
A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. Thomas CP, Andrews JI, Raikwar NS, Kelley EA, Herse F, Dechend R, Golos TG, Liu KZ. J Clin Endocrinol Metab. 2009 Jul;94(7):2524-30. doi: 10.1210/jc.2009-0017. Epub 2009 Mar 31. 10.1210/jc.2009-0017 PubMed 19336504